Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please in Korean Patients With Coronary In-stent Restenosis

Exclusion Criteria

• •Patients with Infarct related artery (IRA) lesions among patients with acute myocardial infarction
• •Patients have restenosis lesions with thrombosis
• •Patients with a history of cardiogenic shock
• •Patients with total occlusion indicating TIMI 0 blood flow at the target lesion (Mehran type IV stenosis)
• •Patients with graft vessel lesion
• •Patients who are contraindicated in aspirin, heparin, clopidogrel, ticlopidine, and paclitaxel
• •Patients with renal insufficiency (eGFR\<30mL/min)
• •Pregnant or lactating women
• •The patients have a life expectancy of less than 12 months
• •Patients who had reduced immunity or clinically significant abnormalities in the laboratory tests (hematological, serum biochemical, and urine tests) performed at the time of screening
• •Patients who had clinically significant disorders in cardiovascular system, digestive system, respiratory system, endocrine system, and central nervous system, or mental illness that significantly affects this study
• •Patients who are unsuitable for the study according to the investigator judges